JP4531558B2 - 免疫細胞を含む３次元膣組織モデル - Google Patents

免疫細胞を含む３次元膣組織モデル Download PDF

Info

Publication number
JP4531558B2
JP4531558B2 JP2004511453A JP2004511453A JP4531558B2 JP 4531558 B2 JP4531558 B2 JP 4531558B2 JP 2004511453 A JP2004511453 A JP 2004511453A JP 2004511453 A JP2004511453 A JP 2004511453A JP 4531558 B2 JP4531558 B2 JP 4531558B2
Authority
JP
Japan
Prior art keywords
cells
tissue
vaginal
cervical
model system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004511453A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005530500A (ja
JP2005530500A5 (https=
Inventor
クラウスナー，ミッチェル
アイヒューニー，セユーン
カビラス，ジョセフ
Original Assignee
マッテク コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マッテク コーポレーション filed Critical マッテク コーポレーション
Publication of JP2005530500A publication Critical patent/JP2005530500A/ja
Publication of JP2005530500A5 publication Critical patent/JP2005530500A5/ja
Application granted granted Critical
Publication of JP4531558B2 publication Critical patent/JP4531558B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/117—Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/1114—T cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/1121—Dendritic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/24—Genital tract cells, non-germinal cells from gonads
    • C12N2502/243—Cells of the female genital tract, non-germinal ovarian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/04—Screening or testing on artificial tissues

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2004511453A 2002-06-07 2003-05-21 免疫細胞を含む３次元膣組織モデル Expired - Fee Related JP4531558B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/165,267 US6943021B2 (en) 2002-06-07 2002-06-07 Three dimensional vaginal tissue model containing immune cells
PCT/US2003/016167 WO2003104393A2 (en) 2002-06-07 2003-05-21 Three dimensional vaginal tissue model containing immune cells

Publications (3)

Publication Number Publication Date
JP2005530500A JP2005530500A (ja) 2005-10-13
JP2005530500A5 JP2005530500A5 (https=) 2006-07-06
JP4531558B2 true JP4531558B2 (ja) 2010-08-25

Family

ID=29710402

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004511453A Expired - Fee Related JP4531558B2 (ja) 2002-06-07 2003-05-21 免疫細胞を含む３次元膣組織モデル

Country Status (6)

Country Link
US (2) US6943021B2 (https=)
EP (1) EP1531677A4 (https=)
JP (1) JP4531558B2 (https=)
AU (1) AU2003239561A1 (https=)
CA (1) CA2488575A1 (https=)
WO (1) WO2003104393A2 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005014149A1 (ja) * 2003-08-07 2005-02-17 Asahi Kasei Kabushiki Kaisha 複合多孔膜とその製造方法
EP1937798A4 (en) * 2005-04-15 2009-05-13 Univ Columbia CHEMICALLY DEFINED CULTURAL MEDIA FOR THE EXPANSION AND DIFFERENTIATION OF EPIDERMIC CELLS AND USES THEREOF FOR THE IN VITRO FARMING OF HAIRFOLLICLES
JP4792566B2 (ja) * 2005-06-01 2011-10-12 財団法人ヒューマンサイエンス振興財団 樹状細胞を含む三次元培養ヒト皮膚モデル
EP1762609B1 (en) * 2005-09-13 2012-04-04 Takara Bio Inc. Serum-free medium for the production of retroviral vectors
WO2007031273A2 (en) * 2005-09-16 2007-03-22 Universität Bern Artificial immune-reconstituted epidermis equivalents
EP2260097B1 (en) * 2008-03-12 2017-04-26 Sanofi Pasteur VaxDesign Corporation Disease model incorporation into an artificial immune system (ais)
JP2010046058A (ja) * 2008-07-24 2010-03-04 Two Cells Co Ltd 治療用培養細胞の製造方法
CN103797110B (zh) 2011-07-12 2017-08-25 食品安全测试系统公司 沙门氏菌和大肠杆菌的培养基和培养方法以及用于检测沙门氏菌和大肠杆菌的方法
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ITMI20120104A1 (it) * 2012-01-30 2013-07-31 Cutech S R L L'utilizzo di tessuto umano proveniente da piccole labbra dei genitali femminili
JP5977580B2 (ja) * 2012-05-24 2016-08-24 秀実 高橋 ランゲルハンス細胞の調製方法
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP3145489A1 (en) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
GB2567269B (en) * 2015-10-22 2021-10-06 Univ Pennsylvania Systems and methods for producing micro-engineered models of the human cervix
CN105483085B (zh) * 2016-02-16 2019-02-26 广州赛莱拉干细胞科技股份有限公司 一种dc细胞培养方法及培养基
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10297085B2 (en) * 2016-09-28 2019-05-21 Intel Corporation Augmented reality creations with interactive behavior and modality assignments
US20180100142A1 (en) * 2016-10-06 2018-04-12 Mattek Corporation Methods and Kits for Production of Tissue Equivalents from Cryopreserved Cells
CN108342322A (zh) * 2018-02-24 2018-07-31 宁夏医科大学总医院 建立原代人子宫内膜上皮细胞气液相培养模型的方法
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
CN113293126B (zh) * 2021-04-01 2023-11-07 广东博溪生物科技有限公司 一种人阴道粘膜模型的体外构建方法
WO2023278286A1 (en) * 2021-06-28 2023-01-05 Mattek Corporation Intestinal and respiratory tissue models containing enterocytes, fibroblasts, immune cells, and endothelial cells
CN115181719B (zh) * 2022-07-13 2023-09-15 福建省海西细胞生物工程有限公司 一种用于培养组织工程表皮的无血清培养基
CN118853540B (zh) * 2024-09-27 2024-12-10 济南磐升生物技术有限公司 一种人阴道上皮模型的体外构建方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79289A (en) 1985-07-05 1992-01-15 Whitehead Biomedical Inst Introduction and expression of foreign genetic material into keratinocytes using a recombinant retrovirus
US5863531A (en) 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5266480A (en) 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5160490A (en) 1986-04-18 1992-11-03 Marrow-Tech Incorporated Three-dimensional cell and tissue culture apparatus
US4963489A (en) 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5032508A (en) 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5902741A (en) 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5478739A (en) 1992-10-23 1995-12-26 Advanced Tissue Sciences, Inc. Three-dimensional stromal cell and tissue culture system
US5627025A (en) 1994-08-12 1997-05-06 The Rockefeller University Method for the identification of compounds capable of abrogating human immunodeficiency virus (HIV) infection of dendritic cells and T-lymphocytes
US5830682A (en) 1994-09-09 1998-11-03 Zymogenetics Preparation of immortalized cells
FR2743817B1 (fr) * 1996-01-23 1998-03-13 Oreal Equivalent de peau comprenant des cellules de langerhans
US5766944A (en) 1996-12-31 1998-06-16 Ruiz; Margaret Eileen T cell differentiation of CD34+ stem cells in cultured thymic epithelial fragments
WO1998051785A1 (en) * 1997-05-14 1998-11-19 The General Hospital Corporation Co-cultivation of cells in a micropatterned configuration
US5968546A (en) 1997-05-16 1999-10-19 Baur; Marcus Keratinocyte culture from precursor cells
EP1538162B1 (en) * 1999-02-24 2012-04-11 North Carolina State University Compositions for altering mucus secretion
DK1264877T3 (da) * 2000-03-16 2013-10-28 Cellseed Inc Celledyrkningsbæremateriale, fremgangsmåde til samdyrkning af celler og samdyrket cellelag opnået derved

Also Published As

Publication number Publication date
JP2005530500A (ja) 2005-10-13
CA2488575A1 (en) 2003-12-18
WO2003104393A3 (en) 2004-08-05
US20030228686A1 (en) 2003-12-11
US6943021B2 (en) 2005-09-13
US20080003677A1 (en) 2008-01-03
AU2003239561A1 (en) 2003-12-22
WO2003104393A2 (en) 2003-12-18
AU2003239561A8 (en) 2003-12-22
EP1531677A2 (en) 2005-05-25
EP1531677A4 (en) 2006-11-29

Similar Documents

Publication Publication Date Title
JP4531558B2 (ja) 免疫細胞を含む３次元膣組織モデル
Abir et al. Morphological study of fully and partially isolated early human follicles
Kruse et al. Cryopreserved human amniotic membrane for ocular surface reconstruction
Lee et al. In vitro differentiation of germ cells from nonobstructive azoospermic patients using three-dimensional culture in a collagen gel matrix
Papini et al. Isolation and clonal analysis of human epidermal keratinocyte stem cells in long-term culture
Dongari-Bagtzoglou et al. Development of a highly reproducible three-dimensional organotypic model of the oral mucosa
EP2297299A1 (en) Methods for preparing human skin substitutes from human pluripotent stem cells
CN1630715A (zh) 一种用于治疗皮肤缺损的可移植性产品的制备方法
Lee et al. Hypoxia-induced apoptosis in endothelial cells and embryonic stem cells
JP3680219B2 (ja) 癌細胞障害性ｔリンパ球の誘導培養方法
Dawe et al. Influence of epithelio‐mesenchymal interactions on tumor induction by polyoma virus
Notara et al. Characterization of the phenotype and functionality of corneal epithelial cells derived from mouse embryonic stem cells
Shwetha et al. Ex vivo culture of oral keratinocytes using direct explant cell culture technique
Epstein et al. P63 expression levels in side population and low light scattering ocular surface epithelial cells
Fossum et al. Long-term culture of human urothelial cells–a qualitative analysis
Dahm et al. Cultivation and characterisation of primary and subcultured equine keratinocytes
Lestari et al. Human spermatogonia stem cells (SSCS) in a culture system with platelet rich plasma and correlations with spermatogenesis level
JP2024054301A (ja) シート状細胞培養物の製造方法
Dong et al. Enrichment of epidermal stem cells by rapid adherence and analysis of the reciprocal interaction of epidermal stem cells with neighboring cells using an organotypic system
RU2628092C1 (ru) Способ получения МСК-ассоциированных недифференцированных гемопоэтических клеток-предшественников с фенотипов CD34+/CD133+
Nagireddy et al. Autologous PRP for the management of thin endometrium in frozen embryo transfer cycles: would it improve the outcome?
Yoo et al. Improved isolation of outer root sheath cells from human hair follicles and their proliferation behavior under serum-free condition
Lamche et al. Primary culture of dispersed skin epidermal cells of rainbow trout Oncorhynchus mykiss Walbaum
Galas Primary culture of ovarian cells for research on cell interactions in the hormonal control of steroidogenesis
CN121914966A (zh) 一种间充质干细胞生物学效力的综合评价方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060519

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060519

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090630

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090930

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091007

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091102

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091110

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091130

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091207

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091225

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100223

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100409

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100511

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100609

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130618

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees